Rigel Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
211,975.00
143,159.00
126,276.00
74,766.00
115,751.00
128,537
Total Accounts Receivable
5,750.00
5,750.00
203.00
-
-
4,077
Other Current Assets
2,350.00
1,628.00
2,545.00
1,448.00
1,682.00
3,479
Total Current Assets
220,075.00
150,537.00
129,024.00
76,214.00
117,433.00
136,987
Net Property, Plant & Equipment
4,455.00
2,509.00
1,613.00
1,156.00
875.00
1,387
Other Assets
1,528.00
1,089.00
1,110.00
764.00
803.00
735
Total Assets
226,058.00
154,135.00
131,747.00
78,134.00
119,111.00
139,109
Accounts Payable
3,903.00
1,613.00
2,763.00
5,563.00
2,636.00
Other Current Liabilities
6,391.00
12,412.00
31,033.00
17,025.00
15,701.00
Total Current Liabilities
10,294.00
14,025.00
33,796.00
22,588.00
18,337.00
Other Liabilities
7,513.00
11,864.00
6,570.00
519.00
128.00
Total Liabilities
17,807.00
25,889.00
40,366.00
23,107.00
18,465.00
Common Equity (Total)
208,251.00
128,246.00
91,381.00
55,027.00
100,646.00
Total Shareholders' Equity
208,251.00
128,246.00
91,381.00
55,027.00
100,646.00
Total Equity
208,251.00
128,246.00
91,381.00
55,027.00
100,646.00
Liabilities & Shareholders' Equity
226,058.00
154,135.00
131,747.00
78,134.00
119,111.00
About Rigel Pharmaceuticals
View Profile
